Medicare AdvantageCoverageMedium impact
MA06.018a, Immune Cell Function Assay
Independence Blue Cross·Allergy & Immunology, Oncology, Hematology +2 more·Medical Policy
Effective date
Dec 19, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.018a for Immune Cell Function Assay has been reissued with an effective date of December 19, 2025. This is a policy update that affects coverage or billing requirements for immune cell function testing procedures under Medicare Advantage plans.
Action Required
By December 19, 2025: Billing team must review the full policy details at the provided URL to understand specific changes to immune cell function assay coverage and billing requirements. Update billing procedures and staff training accordingly based on the complete policy content.